Panorama Noninvasive Prenatal Screen (NIPS) Build info

Synonyms

  • PANORAMA PRENATAL TEST FULL PANEL:PANORAMA TEST PLUS 5 ADDITIONAL MICRODELETIONS
  • PANORAMA
  • NIPT
  • NIPS
  • Panorama Screen
  • NATERA
  • WOMEN'S HEALTH
  • LAB10153

Short Name

PANORAMA PRENATAL TEST FULL PANEL: PANORAMA TEST PLUS 5 ADDITIONAL MICRODEL

Procedure Master Number

LAB10153

Procedure ID

172971

Clinical Info

Panorama can detect chronicity of twin gestation.
Panorama is a blood-based genetic, prenatal screening test of the pregnant person that screens for common chromosomal conditions that affect a baby’s health. Panorama uses SNP*-based technology to deliver highly accurate results and unique insights for both singleton and twin pregnancies.
Panorama can be performed as early as nine weeks gestation. Most results will be returned to your doctor within 5-7 calendar days.

Specimen Type

Blood

Container

Streck

Collection Instructions

Container/Tube: One or two Streck BCT tube
Specimen: 10 ml whole blood (7 ml min)
Required Information:
1) Expected Due Date mm/dd/yyyy
2) Maternal Weight (lbs)
3) Which Microdeletion Panel: Dropdown  None; 22q1,2 Deletion, Expanded Panel)
4) Is this a twin Pregnancy- Dropdown ( No; Monochorionic, Dichorionic, Unsure)
5) Are fetal sex results included No/Yes
6) Is this a surrogate egg donor No/Yes
7) For RhD(-) Patients Only   Yes/No

Transport Instructions

Room Temperture

Specimen Stability

5 Days Room Temperature

Methodology

Nucleic Acid extraction, DNA sequencing, and analysis of sequencing to determine fetal aneuploidy.

Days Performed


Panorama is a screening test, which means that this test does not make a final diagnosis. A high risk result means that your pregnancy has a higher chance of having a specific genetic condition. However, you cannot know for sure if your baby has that condition based upon the screening result alone. All medical decisions should be made after discussion with your healthcare provider regarding diagnostic testing during the pregnancy, like chorionic villus sampling (CVS) or amniocentesis, or testing the baby after birth.

Performing Laboratory

Natera

CPT

81420

PDM

225282

Results
Component Name Base Name Common Name External Name
1P36 DELETION SYN POPULATION-BASED RISK 1P36DELSYNPB 1P36DELSYN POPULATION BASED RISK 1P36 Deletion Syn Population-Based Risk
1P36 DELETION SYNDROME RESULT 1P36DELSYN 1P36DELSYN
1P36 DELETION SYNDROME RISK AFTER TEST 1P36DELSYNRA 1P36DELSYN RISK AFTER 1P36 Deletion Syndrome Risk After Test
22Q11.2 DELETION POPULATION-BASED RISK 22Q112DELPBR 22Q112DELPBR 22Q11.2 Deletion Population-Based Risk
22Q11.2 DELETION RISK AFTER TEST 22Q112DELRA 22Q112DELRA 22Q11.2 Deletion Risk After Test
22Q11.2 DELETION SYNDROME RESULT 22Q112DELSYN 22Q112DELSYN
ANGELMAN SYNDROME POPULATION-BASED RISK ANGELMAN ANGELMAN SYNDROME POPULATION BASED RISK Angelman Syndrome Population-Based Risk
ANGELMAN SYNDROME RESULT ANGELMAN ANGELMAN SYNDROME RESULT Angelman Syndrome Result
ANGELMAN SYNDROME RISK AFTER TEST ANGELMAN ANGELMAN SYNDROME RISK AFTER TEST Angelman Syndrome Risk After Test
CRI-DU-CHAT SYNDR POPULATION-BASED RISK CRIDUPOP CRI DU CHAT SYNDR POPULATION BASED RISK Cri-Du-Chat Syndr Population-Based Risk
CRI-DU-CHAT SYNDROME RESULT CRIDURES CRI DU CHAT SYNDROME RESULT Cri-Du-Chat Syndrome Result
CRI-DU-CHAT SYNDROME RISK AFTER TEST CRIDUSYND CRI DU CHAT SYNDROME RISK AFTER TEST Cri-Du-Chat Syndrome Risk After Test
FETAL FRACTION FETALFRACT FETAL FRACTION
FETAL FRACTION SECOND FETUS FETALFRACT FETAL FRACTION SECOND FETUS
GENDER OF FETUS NTRAGENDER GENDER OF FETUS
GENDER OF SECOND FETUS GENSECFET GENDER OF SECOND FETUS
MONOSOMY X AGE-BASED RISK MONOSOMY MONOSOMY X AGE BASED RISK Monosomy X Age-Based Risk
MONOSOMY X RESULT MONOSOMY MONOSOMY X RESULT Monosomy X Result
MONOSOMY X RISK AFTER TEST MONOSOMY MONOSOMY X RISK AFTER TEST Monosomy X Risk After Test
NATERA FOOTNOTES FOOTNOTES NATERA FOOTNOTES Natera Footnotes
PDF REPORT PDF PDF, REPORT Pdf Report
PRADER-WILLI SYND POPULATION-BASED RISK PRADERWIL PRADER WILLI SYND POPULATION BASED RISK Prader-Willi Synd Population-Based Risk
PRADER-WILLI SYNDROME RESULT PRADERWIL PRADER WILLI SYNDROME RESULT Prader-Willi Syndrome Result
PRADER-WILLI SYNDROME RISK AFTER TEST PRADERWIL PRADER WILLI SYNDROME RISK AFTER TEST Prader-Willi Syndrome Risk After Test
REPORT NOTES REPORTNOTE REPORTNOTE, NOTES Report Notes
REPORT SUMMARY REPRTSUM REPORT SUMMARY
TRIPLOIDY 13 18 AGE-BASED RISK TRIP1318 TRIPLOIDY 13 18 AGE BASED RISK Triploidy 13 18 Age-Based Risk
TRIPLOIDY 13 18 RESULT TRIP1318 TRIPLOIDY 13 18 RESULT Triploidy 13 18 Result
TRIPLOIDY 13 18 RISK AFTER TEST TRIP1318 TRIPLOIDY 13 18 RISK AFTER TEST Triploidy 13 18 Risk After Test
TRIPLOIDY RESULT TRIPRES TRIPLOIDY RESULT Triploidy Result
TRISOMY 13 AGE-BASED RISK TRIS13 TRISOMY 13 AGE BASED RISK Trisomy 13 Age-Based Risk
TRISOMY 13 RESULT TRIS13 TRISOMY 13 RESULT Trisomy 13 Result
TRISOMY 13 RISK AFTER TEST TRIS13 TRISOMY 13 RISK AFTER TEST Trisomy 13 Risk After Test
TRISOMY 18 AGE-BASED RISK TRIS18 TRISOMY 18 AGE BASED RISK Trisomy 18 Age-Based Risk
TRISOMY 18 RESULT TRIS18 TRISOMY 18 RESULT Trisomy 18 Result
TRISOMY 18 RISK AFTER TEST TRIS18 TRISOMY 18 RISK AFTER TEST Trisomy 18 Risk After Test
TRISOMY 21 AGE-BASED RISK TRIS21 TRISOMY 21 AGE BASED RISK Trisomy 21 Age-Based Risk
TRISOMY 21 RESULT TRIS21 TRISOMY 21 RESULT Trisomy 21 Result
TRISOMY 21 RISK AFTER TEST TRIS21 TRISOMY 21 RISK AFTER TEST Trisomy 21 Risk After Test
ZYGOSITY ZYGOSITY ZYGOSITY